XML 55 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Roll Forward
A summary of the status of the Company’s stock option plan as of December 31, 2023, and changes in options outstanding under the plan for the year ended December 31, 2023, is as follows:

Number of
Shares Under Option		Weighted-Average Exercise Price per ShareWeighted-
Average
Remaining
Contractual
Term
(in years)		Aggregate Intrinsic Value
(000’s)(000’s)
Options outstanding at December 25, 2022
18 $4.98 0.0$79.9 
Granted— $— 
Exercised(18)$4.98 
Forfeited or expired— $— 
Options outstanding at December 31, 2023
— $— 0.0$— 
Options exercisable at December 31, 2023
— $— 0.0$— 
Schedule of Grants and Exercises Under the Company's Option Plans
During the years ended December 31, 2023, December 25, 2022, and December 26, 2021, the following values relate to the exercises under the Company’s option plans:

202320222021
Total intrinsic value of options exercised (in thousands)$80.8 $163.0 $— 
Schedule of Restricted Stock Units Activity
The following table summarizes the Company’s Restricted Stock Unit activity:

Restricted
Stock Units
(000’s)		Weighted-Average Grant Date Fair Value
Nonvested balance at December 25, 2022
4,659 $12.88 
Granted1,427 $11.39 
Vested(871)$11.34 
Forfeited or expired(35)$16.12 
Vested but not released(245)$12.55 
Nonvested balance at December 31, 2023
4,935 $— 
Schedule of Assumptions and Resulting Fair Values of Options Granted The assumptions and resulting fair values of options granted for 2023, 2022 and 2021 were as follows:
Offering
Periods
January 1 to
December 31
2023
Offering
Periods
January 1 to
December 31
2022		Offering
Periods
January 1 to
December 31
2021
Expected term (in years)(1)0.50.50.5
Risk-free interest rate(2)
4.76% - 5.47%
0.19% - 2.51%
0.06% - 0.09%
Expected volatility(3)
41.65% - 45.77%
40.52% - 60.79%
41.40% - 45.93%
Expected dividend yield(4)—%—%—%
Weighted average grant-date fair value per share$3.30$4.80$7.60

(1) The expected term is equivalent to the offering period.
(2) The risk-free interest rate is based on U.S. Treasury yields in effect at the time of grant with a term equal to the expected term.
(3) The Company estimated implied volatility based upon trailing volatility.
(4) The Company has no history or expectation of paying dividends on its common stock.